Generate Biomedicines, Inc. GENB

 — 
15.15 (0.84) (5.25%) as of 25 Sep
Market cap
$2.1B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24
Cash and Short Term Investments
221.84 395.05
Receivables
— 0.31
Total current assets
234.37 407.49
Property, Plant, Equpment (Net)
29.15 37.69
Long-term assets (Other)
6.81 9.70
Total non-current assets
95.82 110.77
Total Assets
330.18 518.26
Accounts Payable
3.84 5.67
Accrued Expenses
42.16 21.77
Current Part of Capital Lease
4.31 8.93
Current Revenue (Deferred)
21.19 42.43
Other current liabilities
— 0.05
Total current liabilities
82.20 86.63
Long Term Debt (Total)
2.91 6.45
Non-current Revenue (Deferred)
4.51 15.17
Preferred Shares of Subsidiary (Mandatory, Redeemable)
(7.23) (0.57)
Liabilities (Preferred Stock)
813.03 790.95
Non-current Liabilities (Other)
0.12 0.35
Total non-current liabilities
863.94 866.15
Total liabilities
946.15 952.78
Additional Paid In Capital
60.19 38.47
Common Stock (Net)
0.03 0.03
Retained Earnings
(676.29) (473.14)
Common Equity (Total)
(615.96) (434.52)
Shareholders Equity (Total)
(615.96) (434.52)
Shareholders Equity and Liabilities (Total)
330.18 518.26
Shares (Common)
33.12 32.69
Shareholders Equity (Tangible)
(615.96) (434.52)
Net Debt
(218.93) (388.61)
Total Debt
2.91 6.45

Fold the line items

In millions of $ except per-share values · columns are period end dates